baber/WOPTO huggingface dataset:
Patent DE-69314401-T2 (DE)
Inventor: LUDIKHUIZE ADRIANUS W
IPC: H01L29/812
Filed: 1993-07-13
Granted: 1998-04-09
Abstract: It is usual in high-voltage integrated circuits to provide one or several breakdown-voltage-raising rings at the edge of a high-voltage island in the form of surface zones of the conductivity type opposite to that of the island. According to the invention, the function of these rings is locally taken over by one or several zones forming part of a circuit element and also provided with a breakdown-voltage-raising edge. Since the breakdown-voltage-raising zones are locally omitted alongside the island insulation, a major space saving can be achieved.
Patent DE-69318080-T2 (DE)
Inventor: GELLERT JOBST ULRICH
IPC: B29C45/20
Filed: 1993-07-26
Granted: 1998-08-13
Abstract: A seating and sealing insert (10) for mounting a heated injection molding nozzle (12) in a well (14) in a mold (16). The hollow insert (10) has a cylindrical central portion (86) extending between a rear seating portion (88) and a forward sealing portion (90). The rear seating portion (88) is outwardly flanged to seat in the well (14) in the mold and forms an inner seat (104) to receive a cylindrical support flange (42) of the nozzle to accurately support the nozzle in the well (14) in the mold. The forward sealing portion (90) has a V - shaped forward face (106) and inner and outer surfaces (108,110) which are forced outwardly by melt pressure to seal against the nozzle (12) and the mold (16). Thus, the seating and sealing insert (10) provides an insulative air space (82) between the heated nozzle and the surrounding mold and the forward sealing portion (90) prevents the escape of pressurized melt into the insulative air space (82). <IMAGE>
Patent DE-69320834-T2 (DE)
Inventor: MAKOWER JOSHUA
IPC: A61B19/00
Filed: 1993-12-07
Granted: 1999-01-21
Abstract: A device for measuring the depth below skin level of a blood vessel that has been punctured in the course of a catheterization or other interventional vascular procedure comprises a tubular member having a proximal end and a distal end portion that is preferably tapered to a small outer diameter. The lumen may have a stepped diameter extending between the proximal and distal ends. A first portion of the lumen is distally located and is of a diameter generally equal to the diameter of a guidewire with which the measuring device is used. The second segment of the lumen is of a substantially larger diameter. A side entry port is made through the wall of the tubular member at the distal base of the larger diameter section of the lumen. Graduated markings on the side wall of the tubular member extend from the side entry port toward the proximal end of the instrument. When the instrument is fed over a guidewire into a puncture wound formed through the skin and into an artery, the wall of the artery can be accurately located relative to the skin's surface by noting the graduated markings on the exterior of the tube at the point where blood flow enters the side entry port and fills the larger diameter lumen. Rather than having two coaxially disposed lumens as above, the tubular member may have a double lumen, one extending the entire length for accommodating the guidewire and the other extending between the tube's proximal end and the side entry port.
Patent DE-69321259-T2 (DE)
Inventor: CHAPMAN LEONARD
IPC: B66F11/04
Filed: 1993-12-14
Granted: 1999-02-18
Abstract: A crane arm dolly for supporting a crane arm carrying a camera includes a post pivotally supported on a dolly chassis. Adjustable post support rods support the post. The support rods can be lengthened or shortened to maintain the post in a vertical position when the crane arm dolly is used on an inclined surface.
Patent DE-69333890-T2 (DE)
Inventor: OKUMOTO KOJI
IPC: G01R31/3177
Filed: 1993-05-18
Granted: 2006-07-27
Abstract: A method of testing an electronic apparatus (1) which eliminates a control signal line for setting an integrated circuit (IC1, IC2, IC3) to a test mode and a test mode select terminal of an external terminal section and wherein fetching of test data and transfer of the thus fetched test data are performed in an integrated operation. In each of the integrated circuits, a boundary scan control circuit (8) discriminates a category code (Ci) at the beginning of data inputted from a serial input terminal (SI) to control a pair of switching circuits (SW1, SW2). When the category code represents a test mode, predetermined terminals (b) of the switching circuits (SW1, SW2) are selected so that input data are sent out to boundary scan cells (BC1 to BC8). Fetching of parallel data from parallel input terminals (PI1 to PI4) and transfer to the boundary scan cells (BC5 to BC8) are performed at one time. <IMAGE>
Patent DE-69405873-T2 (DE)
Inventor: COLLIER CHARLES
IPC: C12M1/26
Filed: 1994-07-26
Granted: 1998-04-09
Abstract: A reusable apparatus for multiphase, multistage countercurrent liquid separation is presented. The apparatus is particular useful in progressive multistage separation of target microorganisms from background organisms and materials with precise transfer, air exclusion, homogeneous mixing, isolation from the ambient atmosphere, in the absence of valves and at ow cost. The structure has at least one chamber in which a piston-like sliding bottom is sealingly moved or braked and includes internal structure for mixing, preferably a magnetic-stainless steel ball which can be reciprocated from the outside to mix the liquid contents. Motion of the bottom is limited by stops. A number of ways to actuate the apparatus are taught.
Patent DE-69413935-T2 (DE)
Inventor: VEGEAIS PATRICK
IPC: B41J17/32
Filed: 1994-12-08
Granted: 1999-06-17
Abstract: Cassette (1) for feeding a thermal-transfer printing ribbon (10) in a thermal-transfer printer, the cassette (1) being designed for receiving and for retaining detachably and in their relative position of use a ribbon delivery roller (5) and a ribbon take-up roller (6), each provided with means (8, 9) for fastening in the printer, the cassette (1) leaving the said fastening means (8, 9) disengaged. <IMAGE>
Patent DE-69413973-T2 (DE)
Inventor: TAKAHASHI EIJI
IPC: C08G59/68
Filed: 1994-06-14
Granted: 1999-04-15
Abstract: A sulfonium salt compound represented by general formula (I), useful as a cationic polymerization initiator, wherein R1 represents benzyl, phenyl, etc.; R2, R3 and R4 represent each hydrogen, alkyl, etc.; R5 represents hydrogen, alkyl, phenyl, etc.; R6 represents -(CH2)m- R11, wherein R11 represents COR12, COOR13, OR14, cyano, OCOR15 or SOR16 (wherein R12, R13, R14, R&sub15 and R16 represent each hydrogen, alkyl or phenyl) and m represents O or 1; and X represents SbF6, AsF6, PF6 or BF4. <CHEM>
Patent DE-69425411-T2 (DE)
Inventor: OGURA YUICHIRO
IPC: A61F9/00
Filed: 1994-02-23
Granted: 2001-02-08
Abstract: This invention relates to a sclera plug consisting of a lactocopolymer, a sclera plug containing a drug and designed so as to release the drug gradually into a vitreous body, and a sclera plug used to cure or prevent a retinal disease by utilizing the sustained release action of the drug and promote the healing of a vitreous body after a surgical operation thereon. The sclera plug according to the present invention closes effectively an opening made during a surgical operation on a vitreous body, and need not be removed after the surgical operation. When this sclera plug is used, a drug can be released gradually for a long period of time into intraocular tissues into which the permeating of a drug is otherwise very difficult, so that the administration of a drug can be carried out safely and effectively. Moreover, a simple clinically applicable administration method can be found by utilizing a sclera cut made during a surgical operation on a vitreous body. <IMAGE>
Patent DE-69427367-T2 (DE)
Inventor: KIKINIS DAN
IPC: G06F1/32
Filed: 1994-10-27
Granted: 2001-10-31
Abstract: A system for managing power levels for a general purpose computer having a standby and a full-power mode of operation provides apparatus and a method for monitoring times of user input and control routines for using the times of user input to calculate optimum times for initiating full power operation and standby mode. The control routines are configured to provide the optimum times to a real time clock that remains powered in the standby mode, which triggers switching elements to initiate full power and standby mode. In one embodiment of the system, startup and standby may be initiated either by user input or automatically by the power management system. Startup and standby initiation times may be different for different days and time periods based on both preprogrammed and calculated values.
Patent DE-69430578-T2 (DE)
Inventor: POULSEN ULRIK
IPC: A61M5/20
Filed: 1994-09-27
Granted: 2002-11-28
Abstract: In a displacement system for controlled infusion of a liquid from a cartridge comprising a tubular vessel (1), which is at a rear end closed by a piston (3) which may be forced by a piston rod (8) moving into the vessel (1) in the axial direction thereof to press out the liquid through an outlet (2) arranged at a front end of the vessel (1), the piston rod (8) is provided as a flexible incompressible construction which is by a piston rod guide (9) behind the rear end of the cartridge deflected away from the axis of this cartridge, preferably 180 DEG . The piston rod guide (9) has a guiding track comprising a curved part and linear parts at each end of the curved part ensuring that the piston rod is guided along a length (a) in the direction of the axis of the cartridge which length (a) is longer than the distance (b) between the two axes of the piston rod parts projecting from the piston rod guide. The guiding track is further elaborated to the very shape which the curved part of the piston rod will spontaneously adopt when its end portions are kept parallel.
Patent DE-69433723-T2 (DE)
Inventor: GRINSTAFF MARK W
IPC: A23L33/00
Filed: 1994-02-22
Granted: 2005-02-24
Abstract: In accordance with the present invention, novel formulations have been developed which are much more effective for the delivery of hydrophobic drugs to patients in need thereof than are prior art formulations. Invention formulations are capable of delivering more drug in shorter periods of time, with reduced side effects caused by the pharmaceutical carrier employed for delivery.
Patent DE-69504872-T2 (DE)
Inventor: APELDOORN ADRIANUS
IPC: C02F1/04
Filed: 1995-11-27
Granted: 1999-05-12
Abstract: PCT No. PCT/NL95/00404 Sec. 371 Date Jul. 25, 1997 Sec. 102(e) Date Jul. 25, 1997 PCT Filed Nov. 27, 1995 PCT Pub. No. WO96/16904 PCT Pub. Date Jun. 6, 1996An installation for cleaning oil-polluted water, in particular at oil and gas production plants, is provided with a distillation column having a polluted water feed and at least one contact packing above which the outlet of the polluted water feed is located, a vapor discharge, a clean water outlet and a measuring device for the analysis of the water from the clean water outlet.
Patent DE-69505084-T2 (DE)
Inventor: MARUTA KAZUHIKO
IPC: C12R1/19
Filed: 1995-07-21
Granted: 1999-06-02
Abstract: Disclosed is a recombinant thermostable enzyme which has a molecular weight of about 69,000-79,000 daltons and a pI of about 5.4-6.4, and forms non-reducing saccharides having a trehalose structure as an end unit from reducing amylaceous saccharides having a degree of glucose polymerization of at least 3. The enzyme has satisfactorily high thermostability, i.e. it is substantially not inactivated even when incubated in an aqueous solution (pH 7.0) at 85 DEG C for 60 min, and this facilitates the production of such non-reducing saccharides on an industrial scale and in a satisfactorily-high yield.
Patent DE-69509191-T2 (DE)
Inventor: TANKOVICH NIKOLAI I
IPC: A45D26/00
Filed: 1995-06-05
Granted: 1999-11-18
Abstract: The present invention provides an apparatus for the removal of epidermal skin cells of corneum stratum on a section of human skin, the apparatus including :   a) a light absorbing contaminant capable of infiltrating into the corneum stratum cells when applied to the skin and having a high absorption at at least one frequeny band of light ; and b) an illumination source in spaced apart relation to the contaminant when applied to a section of human skin for illuminating a surface of the section of human skin and the contaminant with pulses of light having sufficient energy to cause the tearing off of the superficial epidermal skin cells of corneum stratum.   <IMAGE>
Patent DE-69515605-T2 (DE)
Inventor: VERTOGEN MARTINUS J M
IPC: B65G15/60
Filed: 1995-12-05
Granted: 2000-08-31
Abstract: The invention relates to a conveyor (1) provided with an endless conveyor belt (1)making a curve, which is near its ends passed over rollers (3,4) journalled in a frame (5), and which can be driven during operation. A collar (7) is provided near one edge of the belt (1) located on the outer side of the curve, which collar (7) is engaged by guide rollers (8) supported by the frame (5). A guide roller (8) engaging a collar (7) is capable of pivoting movement about a pivot axis (11), which extends at least substantially parallel to the belt part (1) supporting the collar (7) in question and which, seen in its longitudinal direction, is located on the side of the collar (7) remote from the side that cooperates with the guide roller (8). Furthermore means (15) are provided by which the guide roller (8) can be locked against being pivoted about the pivot axis (11) when the guide roller (8) is in engagement with the collar (7). <IMAGE>
Patent DE-69518558-T2 (DE)
Inventor: TANIGUCHI TADATSUGU
IPC: C12Q1/6886
Filed: 1995-02-09
Granted: 2001-04-26
Abstract: The present invention relates to a method of diagnosing cancer, precancerous state, and susceptibility to other forms of diseases, by use of a molecular marker, interferon-regulatory factor-1 (IRF-1). The method is characterized in that IRF-1-specific RNA is analysed in a sample obtained from blood or other biopsy material, preferably by reverse transcription/polymerase chain reaction. The invention is based on the unexpected finding that a novel mechanism of inactivation of the tumor suppressor gene IRF-1 plays a crucial role e.g. in hematopoietic malignancies. An unusual exon skipping leads to RNA molecules which lack exon 2 or exons 2 and 3. The relative amounts of full-length RNA and shortened RNA molecules are significantly different in samples obtained from tumor patients as compared to healthy donors. <IMAGE>
Patent DE-69525763-T2 (DE)
Inventor: KATO YOSHIAKI
IPC: C07D333/56
Filed: 1995-04-11
Granted: 2002-10-02
Abstract: A compound represented by formula (I): <CHEM> wherein R1 represents a hydrogen atom, a lower alkyl group or an acyl group; R2 and R3, which may be the same or different, each represents a hydrogen atom, an optionally substituted alkyl group, or an optionally substituted alkenyl group; R4 represents a hydrogen atom, an optionally substituted alkyl group, or an optionally substituted alkenyl group, or R4 forms a double bond between the carbon atom to which R3 is bonded and the adjacent carbon atom to form a benzothiophene skeleton, or R3 and R4 are taken together to form a 5- to 8-membered spiro ring which may contain a hetero atom, e.g., oxygen, sulfur or nitrogen; and n represents an integer of 0 to 2, or a pharmaceutically acceptable salt thereof. The compound of formula (I) exhibits an inhibitory action on the oxidative modification of LDL and is useful as therapeutics of arteriosclerosis.
Patent DE-69531149-T2 (DE)
Inventor: LIKEN A
IPC: G01R19/00
Filed: 1995-03-17
Granted: 2003-12-11
Abstract: A new method for analyzing an electrical waveform of the type portrayed on a graph includes the steps of selecting a waveform to be analyzed, establishing the boundary of a window-like area and generating a signal if the waveform is in a predetermined position with respect to the area. For example, a signal such as a failure signal is generated if the waveform is to be out of the area but, in fact, is in the area. The method also includes features for determining certain parameters, e.g., rise time, period and the like, for the waveform. The steps include selecting first and second points on the waveform and determining the time lapsed between points. Details regarding the structure of a new waveform analyzer are also disclosed.
Patent DE-69600700-T2 (DE)
Inventor: WOLTERS LEENDERT
IPC: F02D35/02
Filed: 1996-01-26
Granted: 1999-05-06
Abstract: Method and device for regulating the NOx emission of an internal combustion engine. It has been found that the NOx emission is dependent on the efficiency of the engine. That is to say the NOx emission can be optimized by determining and controlling the efficiency. This can be performed by making the measured and determined efficiencies equal to one another by altering the air/fuel ratio. <IMAGE>
Patent DE-69612974-T2 (DE)
Inventor: VANOLO PIETRO
IPC: B61F5/12
Filed: 1996-12-24
Granted: 2001-10-25
Abstract: A railway vehicle bogie including a frame (1), two axles (6, 7) connected to the frame (1) through respective journal boxes (12, 13), secondary suspension springs (17) interposed between the frame and a load bearing transom (16) intended to be fixed to vehicle body, and hunting absorbers arranged at the opposite sides of the bogie. The hunting absorbers comprise, at each bogie side, a pair of juxtaposed telescopic dampers (21, 22) placed between the load bearing transom (16) and the journal boxes (12, 13) of the two axles (6, 7). The hunting dampers (21, 22) are inclined both in the vertical plane and in the horizontal plane, and may also act as vertical and/or lateral shock absorbers. <IMAGE>
Patent DE-69630313-T2 (DE)
Inventor: ARAKAWA TSUTOMU
IPC: A61K39/00
Filed: 1996-12-04
Granted: 2004-04-29
Abstract: The present invention relates to an antibody or fragment thereof which recognizes an epitope on a Her2 polypeptide that is recognized by the monoclonal antibody produced by the hybridoma cell line ATCC No. HB-12078. The invention further relates to a hybridoma cell line capable of producing such an antibody. Also, the invention pertains to an  in vitro  method for inducing apoptosis in Her2 expressing cells comprising administering the inventive antibody. Finally, the present invention discloses uses of such an antibody and pharmaceutical compositions comprising the antibody according to the present invention.
Patent DE-69631586-T2 (DE)
Inventor: HOFMANN J
IPC: A61K48/00
Filed: 1996-03-18
Granted: 2005-01-27
Abstract: The present invention relates to expression vectors for HPV18 L1 proteins.
Patent DE-69635548-T2 (DE)
Inventor: KANERVA MIKKO
IPC: H04J3/00
Filed: 1996-12-17
Granted: 2006-08-10
Abstract: PCT No. PCT/FI96/00669 Sec. 371 Date Nov. 26, 1997 Sec. 102(e) Date Nov. 26, 1997 PCT Filed Dec. 17, 1996 PCT Pub. No. WO97/23073 PCT Pub. Date Jun. 26, 1997A digital mobile communication system has a high-speed non-transparent data connection between a transmitting and a receiving party (MS, TAF). For the data connection, parallel subchannels (ch1-chn), corresponding in number to the nominal data transfer rate, have been allocated on the radio interface. A radio link protocol (RLP) is responsible for transmitting data over the radio interface, and for acknowledging correct data frames and for retransmitting defective data frames. A transmission buffer (63) buffers the data frames to be transmitted and stores the data frames transmitted until it receives an acknowledgement of successful reception. In order to reduce interference and power consumption, user data is transmitted by using as many of the allocated subchannels as required by the actual user data rate at any one time. On the other allocated subchannels, transmission is interrupted or discontinuous transmission is activated.
Patent DE-69730052-T2 (DE)
Inventor: DENTON SCOTT
IPC: D21F1/00
Filed: 1997-09-12
Granted: 2004-12-23
Abstract: The present invention is directed towards fabrics formed from yarns of a composite filament structure. The composite filament structure is a high modulus filament material covered with bicomponent filaments and the entire surface area of the high modulus material should be covered. The fabric can be used in clothings for paper making machines and other industrial uses.
Patent DE-69731466-T2 (DE)
Inventor: MORRISON S
IPC: A01N25/00
Filed: 1997-02-21
Granted: 2005-10-20
Abstract: Controlled release insect repellent or insecticide based on a non-aqueous gel composition comprising from about 1 to about 20 weight percent of one or more diblock, triblock, radial block and/or multiblock copolymers, or a mixture thereof, based on synthetic thermoplastic rubbers. The ratio of the diblock copolymer to triblock, radial block and/or multiblock copolymer can be varied from about 0 percent to about 100 percent in either direction. The higher the tri-block percentage, the stiffer the resultant gel. The material to be gelled is a hydrocarbon which based on its physical properties plays an important role in setting the controlled release rate. The composition of the hydrocarbon can vary in carbon chain length from an average of about C-13 to about C-30 and can vary in vapor pressure from about 2.3 mm Hg at 20 DEG  C. to less than about 0.1 mm Hg at 20 DEG  C. The hydrocarbon range on a weight basis is from about 65 to about 95 percent of the total weight of the gelled composition. The controlled release agent or active agent may comprise from about 0.1 to about 30 percent of the gel on a weight basis.
Patent DE-69737329-T2 (DE)
Inventor: BABIN NOELLE
IPC: G01N33/53
Filed: 1997-12-04
Granted: 2007-06-28
Abstract: The invention relates to synthetic biepitope compounds which can be used as standards in immunoassays, for the assay of troponin I, method for preparing them, compositions and kits containing such compounds as well as the immunoassay methods using such compounds.
Patent DE-69803875-T2 (DE)
Inventor: GUBBELS ANTHONIUS
IPC: F24F1/0038
Filed: 1998-11-19
Granted: 2002-11-07
Abstract: The invention relates to a stable comprising a floor, upright walls bounding said floor, in which walls one or more fans are present, and a roof covering a space bounded by said floor and said walls, in which roof means for exhausting spent air are present, which spent air is used for controlling the temperature of the air to be supplied, wherein said fans supply conditioned air essentially at floor level, wherein the amount of air to be supplied and the temperature thereof can be controlled for each fan individually.
Patent DE-69815514-T2 (DE)
Inventor: HADDEN W
IPC: G09F5/04
Filed: 1998-01-12
Granted: 2003-12-11
Abstract: A carpet sample book is constructed from a single sheet of cardboard or other suitable material. The sheet is creased to define a number of panels. The sheet may be folded over itself to make the panels several layers thick. Cutouts are made through some or all of the layers to holding carpet samples. The creases act like hinges which allow the panels to be folded over each other so that the entire assembly can be folded into a compact book.
Patent DE-69818213-T2 (DE)
Inventor: SOLURI ALESSANDRO
IPC: G01T1/164
Filed: 1998-04-22
Granted: 2004-07-01
Abstract: The miniaturized gamma camera has all specific functionalities of gamma cameras, with extremely high spatial resolution (about 1-2 mm) and dimensions of about 22 mmx22 mm of active area and total size of about 35 mmx35 mm, such as to fit in one of the surgeon's hands and to be handled with absolute ease.
Patent DE-69819360-T2 (DE)
Inventor: WOLLOWITZ SUSAN
IPC: A61L2/00
Filed: 1998-11-20
Granted: 2004-08-19
Abstract: Psoralen compound compositions are synthesized which have primaryamino substitutions on the 3-, 4-, 5-, and 8-positions of the psoralen, which yet permit their binding to nucleic acid of pathogens. Reaction conditions that photoactivate these psoralens result in the inactivation of pathogens which contain nucleic acid. The compounds show similar activity in test systems to 4' and 5' derivatives of psoralen useful for inactivation of pathogens in blood products. In addition to the psoralen compositions, the invention contemplates such inactivating methods using the new psoralens.